ERBB2 and neoplasm: Locally assessed HER2-low status was associated with lower odds of pCR occurrence; however, only when the effect was not adjusted for any patient’s or tumor’s characteristics (unadjusted OR = 0.62, 95%CI 0.38–1.00; adjusted OR = 0.79, 95%CI 0.45–1.40).